TurtleTree Secures FDA Approval for Cow-Free Lactoferrin

TurtleTree has received the first ‘no questions’ letter from the US FDA for its precision-fermented lactoferrin, marking a significant regulatory milestone. This approval enhances the startup’s credibility and opens pathways for global expansion, addressing supply shortages in the lactoferrin market, which is crucial for various health applications.

Original excerpt: TurtleTree has secured the first ‘no questions’ letter for precision-fermented lactoferrin from the US Food and Drug Administration…

Source: Green Queen